Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
TRANEXAMIC ACID INJECTION OMEGA LABORATORIES LIMITED Actual shortage 100MG Updated Report 2024-10-22 238410
POTASSIUM ACETATE INJECTION USP OMEGA LABORATORIES LIMITED Actual shortage 39.2% Updated Report 2024-10-22 237160
DEXAMETHASONE-OMEGA OMEGA LABORATORIES LIMITED Actual shortage 4MG Updated Report 2024-10-22 237157
POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE OMEGA LABORATORIES LIMITED Actual shortage 200mEq Updated Report 2024-10-22 240180
ROCURONIUM BROMIDE INJECTION HIKMA CANADA LIMITED Anticipated shortage 10MG New Report 2024-10-22 240847
MYOVIEW 30ML GE HEALTHCARE CANADA INC Anticipated shortage 1.38MG Updated Report 2024-10-22 240653
TOBI PODHALER BGP PHARMA ULC Anticipated shortage 28MG Updated Report 2024-10-22 236492
MYLAN-MIRTAZAPINE MYLAN PHARMACEUTICALS ULC Actual shortage 45MG Updated Report 2024-10-22 230092
MYLAN-GLICLAZIDE MR MYLAN PHARMACEUTICALS ULC Actual shortage 30MG New Report 2024-10-22 240838
CADUET BGP PHARMA ULC Resolved 80MG 5MG Updated Report 2024-10-22 234685

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
HUMATROPE ELI LILLY CANADA INC To be discontinued 24MG 3.15ML New Report 2024-10-18 240682
HUMATROPE ELI LILLY CANADA INC To be discontinued 12MG 3.15ML New Report 2024-10-18 240679
HUMATROPE ELI LILLY CANADA INC To be discontinued 6MG 3.15ML New Report 2024-10-18 240676
HUMALOG ELI LILLY CANADA INC To be discontinued 100UNIT Updated Report 2024-10-15 224347
TD ADSORBED SANOFI PASTEUR LIMITED Discontinued 5LF 2LF Updated Report 2024-10-15 206909